Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...

On April 10, 2024, the U.S. Department of Justice announced it had filed a complaint against Regeneron under the False Claims Act. According to the DOJ, the Company failed to report millions of ...

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

Learn more about whether Lantheus Holdings, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Enovis Corporation or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

U.S. Capital Wealth Advisors LLC grew its stake in shares of American International Group, Inc. (NYSE:AIG – Free Report) by ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

U.S. Capital Wealth Advisors LLC lifted its holdings in shares of Eastman Chemical (NYSE:EMN – Free Report) by 4.3% during the 4th quarter, according to its most recent Form 13F filing with the ...

The adjusted risk for COPD was elevated among adults who identified as regular cigarette smokers before age 15 years, ...